Hormonal regulation of adenylate cyclase activity in circulating lymphocytes and its interrelationship with hormone sensitivity of tumor tissue in colorectal cancer patients.
The purpose of this study was to investigate the peculiarities of hormonal regulation of adenylate cyclase (AC) of blood lymphocytes in colorectal cancer patients and to compare these peculiarities with hormone sensitivity of AC of colorectal tumors and normal colonic mucosa. Basal and stimulated lymphocyte AC activity was studied in 51 healthy persons and 52 cancer patients (14 with colon cancer, 21 with rectal cancer and 17 with stomach cancer) aged 20-75 years. In 31 of 35 patients with colorectal cancer the AC activity was studied simultaneously in lymphocytes, tumor tissue and normal colonic mucosa. To evaluate basal and stimulated AC activity the measurement of c-AMP (Amersham kits) formed in the presence of ATP regenerating system was used. Basal and by VIP, pentagastrin and sodium fluoride stimulated AC activity in lymphocytes of gastrointestinal cancer patients was lower than in lymphocytes of healthy subjects of similar age. Stage dependence of the parameters under study was not found. There was a tendency for higher basal and stimulated lymphocyte AC activity in colon cancer patients as compared to stomach and rectal cancer patients. In colorectal cancer patients the peculiarities of lymphocyte AC reactions to stimulation were closer to those in tumor tissue but not to those in normal colonic mucosa. The reaction of lymphocyte AC to VIP and glucagon coincided more frequently with tumor AC reactions to the same hormones in case of hormone nonsensitive tumors. Thus, basal and stimulated lymphocyte AC activity in colorectal cancer patients was modified to some degree by tumor factors. Lymphocyte AC reactions to VIP and glucagon may be considered as indirect markers of hormone sensitivity of colonic tumors. Moreover, the probability of discovery of hormone nonsensitive tumors by this way is more reliable than hormone sensitive ones.
Berstein
L M
LM
N.N. Petrov Research Institute of Oncology, St. Petersburg, Russia.
Pravosudov
I V
IV
Kryukova
O G
OG
D000255:Adenosine Triphosphate / Q000502:physiology; D000262:Adenylyl Cyclases / Q000378:metabolism*; D000328:Adult; D000368:Aged; D002116:Calcitonin / Q000502:physiology; D003110:Colonic Neoplasms / Q000201:enzymology*; D004837:Epinephrine / Q000502:physiology; D005934:Glucagon / Q000502:physiology*; D006801:Humans; D007413:Intestinal Mucosa / Q000201:enzymology; D008214:Lymphocytes / Q000201:enzymology*; D008875:Middle Aged; D010418:Pentagastrin / Q000378:metabolism; D012004:Rectal Neoplasms / Q000201:enzymology*; D012969:Sodium Fluoride / Q000378:metabolism; D013274:Stomach Neoplasms / Q000201:enzymology; D014660:Vasoactive Intestinal Peptide / Q000502:physiology*
D014660:Vasoactive Intestinal Peptide; D000255:Adenosine Triphosphate; D012969:Sodium Fluoride; D002116:Calcitonin; D005934:Glucagon; D000262:Adenylyl Cyclases; D010418:Pentagastrin; D004837:Epinephrine